The Rheumatology Podcast

Apr 01 2022 144 ep. 8 mins 752
The Rheumatology Podcast artwork

Rheumatology provides free podcast interviews with experts in the field on key topics.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Trainee Publishing Programme 2021: Dr Sreejitha Sreevilasan

Nov 23 2021 9 mins  
As one of the winners of our 2021 Trainee Publishing Programme, Dr Sreejitha Sreevilasan (Hyderabad, India) talks to Dr David Liew about clinical profile and treatment outcomes in antisynthetase syndrome. They discuss the key findings from Dr Sreevil

Dr. Iona Thorne on reproductive health in women with rheumatic disease

Aug 24 2021 14 mins  
Prithvi Gaur and Dr. Iona Thorne (Chelsea and Westminster NHS Hospitals Foundation Trust) discuss the 2019 MHRA drug safety update, which includes pregnancy prevention guidance for women treated with potentially teratogenic drugs.

Dr Steven Zhao on comorbidities and disease activity in axSpA

Dec 31 1969 7 mins  
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.

Dr Marwan Bukhari talks to Dr Helena Marzo-Ortega on the use of MRI in the diagnosis of axSpA

Oct 17 2019 6 mins  
Dr Marwan Bukhari talks to Dr Helena Marzo-Ortega about her recent papers on the use of MRI in the diagnosis of axial spondyloarthritis (axSpA).

Dr Peter Grayson on VEXAS syndrome

May 14 2021 21 mins  
Dr Puja Mehta and Dr Peter Grayson (NIH, Bethesda, MD, US) discuss VEXAS syndrome.

Treating IgG4-related disease with rituximab

Sep 12 2016 7 mins  
Dr James Galloway and Dr Justin Mason, discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients.

NEIAA: Predicting disease activity in early inflammatory arthritis

Apr 22 2021 12 mins  
Dr Marwan Bukhari talks to Paul Amlani-Hatcher (NEIAA Patient Panel Chair) and Dr James Galloway (King’s College, London) about findings from the BSR National Early Inflammatory Arthritis Audit (NEIAA).

RA patient access to DMARDs in Norway

Sep 19 2016 5 mins  
Dr James Galloway and Dr Samantha Hider, Keele University, UK discuss a paper by Polina Putrik et al. which looked at access to DMARDs.

Frequency of anti-infliximab antibodies: patients with RA in routine care – (May 2013)

Jul 04 2013 12 mins  
Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al

Guidance on prescribing drugs in pregnancy and breastfeeding – May 2016

May 25 2016 5 mins  
Dr Marwan Bukhari and Dr Ian Giles (University College London Hospital, UK) discuss the treatment of rheumatic problems in relation to pregnancy and the BSR and BHPR guideline on prescribing drugs during pregnancy. They discuss the key findings an